Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America-Reference-Cited by-同舟云学术

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America

Published:2022-01 Issue:1 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Orozco‐Levi Mauricio¹²³⁴,Cáneva Jorge⁵,Fernandes Caio⁶,Restrepo‐Jaramillo Ricardo⁷,Zayas Nayeli⁸,Conde Rafael⁴⁹,Diez Mirta¹⁰,Jardim Carlos⁶,Pacheco Gallego Manuel C.⁴¹¹¹²¹³¹⁴,Melatini Luciano¹⁵,Valdéz Héctor¹⁶,Pulido Tomás⁸

Affiliation:

1. Respiratory Department Hospital Internacional de Colombia Bucaramanga Colombia

2. EMICON Research Group, MINCIENCIAS Bogotá Colombia

3. Universidad de Santander (UDES) Bucaramanga Colombia

4. Red Colombiana de Hipertensión Pulmonar (HAPred.co) Colombia

5. Respiratory Department Hospital Universitario Fundación Favaloro Buenos Aires Argentina

6. Pulmonary Division, Pulmonary Circulation Unit, Pulmonary Division, Heart Institute University of São Paulo Medical School São Paulo Brazil

7. University of South Florida Tampa Florida USA

8. Cardiopulmonary Department National Heart Institute Mexico City Mexico

9. Critical Medicine and Intensive Care, Pulmonology, Vascular Pulmonary Center Fundación Neumológica Colombiana Bogotá Colombia

10. Cardiology Department Instituto Cardiovascular Buenos Aires Buenos Aires Argentina

11. Colombian Association of Pulmonology and Chest Surgery Pereira Colombia

12. Universidad Tecnológica de Pereira Pereira Colombia

13. Universidad Autónoma de las Americas Pereira Colombia

14. Respiremos, Respiratory Care Unit Pereira Colombia

15. Respiratory Medicine Center for Advanced Complexity Respiratory Studies Bahia Blanca Argentina

16. Pulmonary Function Department Mexican Social Security Institute Monterrey City Mexico

Funder

Bayer

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12012

Reference29 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Galiè N;Eur Respir J,2015

2. An evaluation of long‐term survival from time of diagnosis in pulmonary arterial hypertension from the reveal registry;Benza RL;Chest,2012

3. Five‐year outcomes of patients enrolled in the REVEAL registry;Farber HW;Chest,2015

5. Systematic review of the economic burden of pulmonary arterial hypertension;Gu S;Pharmacoeconomics,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Solutions;CHEST;2024-03

2. Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension;Pulmonary Circulation;2023-07